Tokyo, Japan

Takuya Kato

This inventor holds 24 USPTO granted patents and 8 published patent applications, plus 3 CIPO patents and 8 EPO patents, primarily in Color Conversion Technology. Top assignees: Nok Corporation, Sony Corporation, Oji Holdings Corporation. Active years: 1990-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Takuya Kato. Retrieved from https://idiyas.com/inventor/takuya-kato

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 24 

% Patents Active = 83.3

 

 

Average Co-Inventor Count = 2.5

ph-index = 5

Forward Citations = 201(Granted Patents)


Location History:

  • Tokyo, JP (1990 - 2022)
  • Chiba, JP (2022)
  • Fukushima, JP (2019 - 2023)

Company Filing History:


Years Active: 1990-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Color Conversion Particle
Sealing Apparatus
Pentosan Polysulfate
Moisturizing Topical Preparation
Zoom Lens
Image Processing Device
Pharmaceutical Composition
Dust Seal
Polymer Conjugate
Communication Terminal
Semiconductor Memory
24 patents (USPTO):Explore Patents

Title: The Innovative Journey of Takuya Kato: A Pioneer in Pentosan Polysulfate Development

Introduction: Takuya Kato is a prominent inventor based in Tokyo, Japan, renowned for his contributions to the field of biochemistry and pharmaceutical sciences. With a remarkable portfolio of 14 patents, Kato has dedicated his career to advancing the development of pentosan polysulfate, a compound with significant therapeutic potential.

Latest Patents: Takuya Kato's recent innovations include groundbreaking patents for pentosan polysulfate and methods for its production. His work describes a pentosan polysulfate characterized by a uronic acid content ranging from 0.0% to 6.0% by mass. The structural formulation defined in his patents allows for various substituents represented by R, which can include functional groups such as COCH and SOX, where X denotes a hydrogen atom or a metal ion. Kato's methods for producing this compound involve a systematic approach—starting from the depolymerization of plant-derived materials to yield neutral xylooligosaccharides, followed by sulfating these oligosaccharides. His optimized procedures not only ensure higher yields but also maintain low acetyl group content, thereby enhancing the efficiency and cost-effectiveness of pentosan polysulfate production.

Career Highlights: Throughout his career, Takuya Kato has held pivotal roles in reputable companies such as Sony Corporation and Oji Holdings Corporation. His extensive experience in these organizations has significantly influenced his inventive capabilities, allowing him to leverage both technological advancements and industry insights for his research and development endeavors.

Collaborations: Kato's inventive path has been enriched by collaborations with esteemed colleagues, notably Kotaro Ishikawa and Takuro Kashiwamura. Their collective expertise and shared vision have driven innovation and facilitated the practical application of Kato's inventions in the pharmaceutical sector.

Conclusion: Takuya Kato exemplifies the spirit of innovation through his dedication to developing sophisticated compounds like pentosan polysulfate. His contributions not only highlight his individual talent as an inventor but also emphasize the collaborative nature of scientific advancement. As the field continues to evolve, Kato's patents stand as a testament to the critical role of innovation in improving healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…